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Recent advances in sample preparation and analysis for next generation sequencing have
made it possible to profile and discover new miRNAs in a high throughput manner. In
the case of neurological disease and injury, these types of experiments have been more
limited. Possibly because tissues such as the brain and spinal cord are inaccessible for
direct sampling in living patients, and indirect sampling of blood and cerebrospinal fluid are
affected by low amounts of RNA. We used a mouse model to examine changes in miRNA
expression in response to acute nerve crush. We assayed miRNA from both muscle tissue
and blood plasma.We examined how the depth of coverage (the number of mapped reads)
changed the number of detectable miRNAs in each sample type. We also found that sam-
ples with very low starting amounts of RNA (mouse plasma) made high depth of mature
miRNA coverage more difficult to obtain. Each tissue must be assessed independently for
the depth of coverage required to adequately power detection of differential expression,
weighed against the cost of sequencing that sample to the adequate depth. We explored
the changes in total mapped reads and differential expression results generated by three
different software packages: miRDeep2, miRNAKey, and miRExpress and two different
analysis packages, DESeq and EdgeR. We also examine the accuracy of using miRDeep2
to predict novel miRNAs and subsequently detect them in the samples using qRT-PCR.
Keywords: miRNA, small RNA, nerve injury, analysis, next generation sequencing, plasma, muscle
INTRODUCTION
miRNAs are small non-coding RNAs ∼22 nucleotides in length
that regulate gene expression by altering mRNA stability and tran-
scription. miRNAs are thought to regulate at least 30% of genes
and are involved in most cellular processes (Ebert and Sharp,
2012; Espinoza-Lewis and Wang, 2012; Ponomarev et al., 2012),
including disease (Provost, 2010; Schroen and Heymans, 2012;
Shantikumar et al., 2012). As a result, miRNA expression profiling
studies have been effective in identifying specific miRNA signa-
tures in a variety of developmental stages and diseases (Natarajan
et al., 2012; Nikitina et al., 2012; Pritchard et al., 2012; Weiland
et al., 2012). Most of these studies have occurred in the fields
of cancer research, diabetes, and cardiovascular disease. Studies
examining miRNA changes associated with neurological disease
and injury have lagged behind.
The lag in miRNA studies of neurological and neurodegenera-
tive disease is in part due to our inability to directly test affected
tissues and cells from living subjects. Indirect sampling of miRNAs
in blood and cerebrospinal fluid, because of their small amounts
of total RNA, have not easily leant themselves for profiling by
next generation sequencing (NGS). Recent advances in library
sample preparation have introduced new and sensitive protocols
that have improved our ability to differentiate changes in miRNA
expression levels, even from samples with low amounts of RNA.
Deep sequencing allows for massive parallel quantification and
evaluation of the miRNA composition in a large number of sam-
ples at one time. Using the Illumina NGS platform, we routinely
barcode and sequence up to 175 small RNA samples per flow cell
on the HiSeq 2000. The bias associated with multiplexing sam-
ples has also made vast improvements in the new types of sample
preparation. Instead of ligating a barcode directly to the miRNA
and introducing bias through ligation efficiency, the same adaptor
sequence is ligated to all of the samples and the individual barcode
is introduced by PCR, resulting in virtually no bias (Post Amplifi-
cation Ligation-Mediated multiplexing; Van Nieuwerburgh et al.,
2011). The technique accommodates many different sample types
(Osanto et al., 2012; Semenov et al., 2012; Wang et al., 2012), mak-
ing NGS of miRNAs increasingly more accessible, cost efficient,
and quantitative.
As the protocols for miRNA library preparation for deep
sequencing have improved, the real challenge has become how
to appropriately adapt, and integrate better analysis tools. As we
began our experiments using small RNA NGS data, we were uncer-
tain how many initial reads and mapped reads per sample library
we should acquire, what variation in the number of initial vs.
mapped reads to expect between biological replicates and from
different sample types – for example, tissue vs. acellular fluid. We
needed to determine how many miRNAs we could detect in tissue
vs. plasma samples, which alignment and miRNA detection soft-
ware to choose, and what analysis software to use. We describe our
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experiences using three different software programs (miRNA Key,
miRDeep2, and miR Express) and two different analysis pack-
ages to detect significant, differentially expressed miRNAs using
EdgeR and DESeq. We used experimental data from acute nerve
injury. We sequenced miRNA from whole gastrocnemius muscle
and blood plasma collected from mice 7 days after they received
a sciatic nerve crush or an identical surgical procedure minus the
crushed nerve (sham-surgery). In this report, we discuss our expe-
rience sequencing these two sample types and taking our data
through all three alignment tools and both analysis programs, and
finally we present the differentially expressed miRNAs identified
by each pipeline. Although each lab, each tissue, and each experi-
mental manipulation will have to be evaluated individually for its
own inherent variability, there are common conclusions that can
be drawn.
MATERIALS AND METHODS
ANIMAL SURGERY AND HANDLING
Experimental procedures and animal handling were performed
using protocols approved by the Institutional Animal Care and
Use Committee at the Barrow Neurological Institute, St. Joseph’s
Hospital, and Medical Center.
Six-week-old C57BL6 mice were used for all experiments. Ten
mice were deeply anesthetized using intraperitoneal injections of
80 mg/kg ketamine and 10 mg/kg xylazine, in addition to atropine
(0.02 mg/kg) to reduce bronchial secretion. Animals were placed
on their left side to expose the right Quadriceps muscle. The
hair on the thigh was clipped and the area thoroughly sterilized.
An incision through the skin was made using a scalpel. A blunt
dissection was made into the right thigh, between the Gluteus
Maximus and Quadriceps muscles (procedure according to Luís
et al., 2007; Mazzer et al., 2008). A Schwartz micro clip (non-
serrated) with ∼795 gm of occluding pressure (Roboz) was used
to clamp the sciatic nerve for 10 s. This was enough time and pres-
sure to see significant flattening of the sciatic nerve. The muscle
and skin were then closed with 5/0 sutures. Animals were given
7.5 mg/kg Ibuprofen orally for 3 days following the procedure.
Seven days post-procedure, the animals were anesthetized, and
blood removed by cardiac puncture using a syringe attached to a
25G scalp vein needle and tubing (Exel). The right Gastrocnemius
muscle (innervated by the crushed sciatic nerve) was also removed
at that time. Ten animals received a sham-surgery, the procedure
was identical to the sciatic nerve crush; the muscle was cut and
the nerve exposed, but the nerve was not touched. The animals
were sutured, monitored, and given same dose of Ibuprofen for
the same number of days as the animals that received a crush to
the sciatic nerve. The blood and right Gastrocnemius muscle was
removed 7 days later. For different reasons, the final number of
mice in each group was nine.
TISSUE HANDLING AND RNA ISOLATION
Immediately upon removal, the Gastrocnemius muscle was flash
frozen in liquid nitrogen and transferred to the −80˚C freezer
until processing. The muscle tissue was crushed on dry ice using a
15 mL Ultra Tissue Grinder (Fisher). Once the tissue was crushed
to powder, the first buffer of the mirVana PARIS kit (Cell Disrup-
tion Buffer) was added. The samples were then sonicated using a
Covaris Sonolab (Covaris Inc) with the following settings: 2× 5%
dc500 mV 100 cb.tmt for 5 s, 2× 20% dc500 mV 50 cb.tmt for
15 s, 2× 20% dc500 mV 100 cb.tmt for 15 s, 2× 5% dc500 mV
100 cb.tmt for 5 s. We then continued with the protocol of the mir-
Vana PARIS kit (Invitrogen). For muscle tissue, we measured total
RNA using Nanodrop and used 1µg in library preparation. Once
blood was collected from the mice, the blood samples were spun
at 2000× g for 10 min (within 30 min of blood draw). Plasma was
then aliquoted into 1.5 mL vials, flash frozen in liquid nitrogen,
and stored at−80˚C. For RNA isolation, the samples were allowed
to thaw in the presence of 2×Denaturing Buffer (mirVana PARIS
kit) and then we continued with the protocol from the kit. We used
the mirVana PARIS kit and followed the protocol for total RNA
isolation, eluting in 100µl water. We then precipitated the RNA in
ammonium acetate (Sigma) and resuspended the RNA in 7.5µl
of RNase-free water. About 4.5µl were then used to begin library
sample preparation.
SEQUENCING
Total RNA, that included small RNA, was used as the starting mate-
rial in the TruSeq small RNA sample preparation from Illumina
(v1.5). In order to select small RNA species from total RNA, the 3′
Illumina adaptor contains a 5′ P and in the presence of truncated
T4 RNA ligase (no ATP added) it is selective for RNAs with a 3′
hydroxyl group (resulting from mature miRNA cleavage by Dicer).
We used Illumina indexes 1–48, we followed the TruSeq protocol
exactly and used 12 cycles of PCR amplification for gastrocnemius
muscle and 15 cycles for plasma. Each library was examined on
the bioanalyzer after library preparation to ensure that the samples
were the proper size, had little adaptor contamination, and to esti-
mate the sample concentration. If there was too much adaptor, the
library could be rerun on a 6% TBE gel and re-purified away from
the adaptor band. About 5000 pM of 10–24 samples were added
to each pool, each pool was loaded at 9 pM concentration per lane
for version 2 flow cells and 5 pM for version 3 flow cells. We used
the bioanalyzer for calculating pM. We have noticed that the cor-
relation between pM loaded and cluster density can vary greatly
depending on the person that prepares the library. Therefore, for
all of our experiments only one person prepared the libraries for
the entire experiment. Using these parameters, we get an average
of 415–710 clusters per mm2 per flow cell lane. miRNA sample
libraries do not contain enough nucleotide diversity for the phas-
ing and pre-phasing to be accurately calculated. Therefore, on all
of our flow cells we dedicate one entire lane to a PhiX control, this
allows the software to calculate the phasing and pre-phasing values
for the whole flow cell. We processed our samples using TruSeq
SBS Kit (v3) for 50 cycles of sequencing and for 7 cycles of the
indexing read. The Q30 scores stayed above 90% throughout the
sequencing run.
POST-SEQUENCING ANALYSIS PIPELINE
Sequence generation and pre-alignment filtering
Raw sequences were obtained and were de-multiplexed using the
Illumina pipeline CASAVA v1.8. The FastQC1 and FASTX toolkit2
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc
2http://hannonlab.cshl.edu/fastx_toolkit
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were used for Quality Check [ensured that fastq reads are in
entirely normal (green tick: ≥Q28) range in the QC report]
and to preprocess the reads prior to mapping respectively. The
fastx_clipper tool was employed to remove the Illumina three
prime adapter (TGGAATTCTCGGGTGCCAAGG) sequences and
retaining a minimum read length of 18 bp after clipping.
miRNA mapping tools
We used MiRDeep2 (Friedländer et al., 2012), miRNAKey (v1.2;
Ronen et al., 2010), and miRExpress (V2.1.3; Wang et al., 2009)
for the analysis. All the runs were carried out using the default
parameters suggested by the creators of the tools and allowing up
to one single nucleotide variation (SNV).
miRDeep2
Clipped reads were aligned using mapper.pl to Mouse genome
(mm9) and miRBase_v18 (mmu sequences) and further processed
using miRDeep2.pl scripts. The csv files for miRNA expression
from mirDeep2 were used for further analysis.
miRNAKey
Incorporates the Seq-EM algorithm to optimize the distribution
of multiple aligned reads among the miRNAs expressed, and does
not discard them. Output is read counts and RPM index (the Read
Count normalized to a million mapped reads in the input file)
values obtained by mapping against mature miRNA sequences of
mouse.
miRExpress
Alignments of the reads are carried out against mature miR-
NAs from the reference genome (mouse) based on the Smith–
Waterman algorithm. The read counts for each miRNA aligned
were used for the downstream analysis.
qRT-PCR
We ordered custom TaqMan MiRNA Assays from Applied Biosys-
tems using unique miRNA sequences identified in reads sequenced
in our samples by miRDeep2 that did not align with known mouse
miRNA sequences in miRBase. These samples received a range of
miRDeep2 scores, and were present in every sample. qRT-PCR was
preformed using RNA from the right gastrocnemius muscle, 10 ng
of total RNA (that includes the small RNA) was put in the reverse
transcription (RT) reaction. The three unique sequences were: 5′-
ucaggucccuguucgggcgcca-3′, 5′-ucacccuggacugacucucagg-3′, and
5′-agccccucugagacucugaaaga-3′. The RT reaction and PCR ampli-
fication were performed according to Taq protocol from Applied
Biosystems using a Roche 480 light cycler. The RT reaction was
diluted 1:15, in the Universal PCR Master Mix with no AmpErase
UNG, according to the Applied Biosystems protocol. Our two pos-
itive loading controls were: snoRNA55 and snoRNA135. We also
ran a no template control, in every case the no template control
did not cross threshold and in every case our positive controls
did call. We followed the same protocol for the qPCR validation
experiments with tissue. In this case U6 was used as a control.
C. elegans miRNAs were used to examine sensitivity to changes
in expression detectable by sequencing. C. elegans miRNAs cel-
miR-39, cel-miR-54, and cel-miR-238 (ordered as custom RNA
oligonucleotides from IDT). A mix of these miRNAs at 25 fmol
each was prepared and flash frozen in 10µl aliquots. A volume
of 1.5µl of the mix was added to 120µl of water. About 1.67µl
were then used in the RT reaction (5µl reaction). About 28.9µl of
water were added to the cDNA, and 2.25µl were used in the Taq
reaction (as in Mitchell et al., 2008).
We then diluted the reaction in half and measured theCp values
for both.
STATISTICAL ANALYSIS
Differential expression of miRNA read counts identified by miRD-
eep2, miRNAKey, and miRExpress was performed using two
packages designed to work with RNA based read count data.
Two groups were considered for paired comparisons: (i) samples
receiving sham-surgery, and (ii) samples with nerve crush.
EdgeR implementation utilizes a negative binomial distribution
to model discrete count data. Although EdgeR does not trans-
form counts to normalized RPKM values, the read count data
is normalized for compositional bias in sequenced libraries and
for differences between libraries in sequencing depth. The data is
first scaled to library size followed by normalizing the data with
weighted trimmed mean of the log expression ratios, a method
known as trimmed mean of M values (TMM). We then estimate
dispersion of the reads counts and perform an exact test between
the groups (Robinson et al., 2010).
DESeq uses a similar approach as EdgeR while extending the
model to provide a better fit for the data. The data is adjusted to
a common scale by normalizing it for different library size. Sec-
ondly, the data’s (miRNA) dispersion from the mean is estimated,
which provides the basis for inference. The final step is to compute
differential expression and estimate p-values (Anders and Huber,
2010).
p-Values were adjusted for multiple testing with Benjamini
and Hochberg (1995) approach for adjusting the false discovery
rate (FDR) and adjusted p-values were filtered at 0.05. For bio-
logical target prediction of the differentially expressed miRNAs,
we used TargetScan (Lewis et al., 2005) or DIANA-microTest 3.0
(Maragkakis et al., 2009).
RESULTS
We used an acute nerve injury model for these experiments. We
had two groups; (1) 10 six-week-old mice underwent a surgical
procedure to crush the sciatic nerve in their right leg. A bulldog
clip with constant pressure was placed around the sciatic nerve
for 10 s. The sciatic nerve was visibly flattened, the animals were
sutured and allowed to recover in their home cages for 7 days. (2)
10 six-week-old mice received a sham-surgery, the sciatic nerve
was exposed in the same way as in the animals in group 1, but
the nerve was not crushed. We allowed the animals to recover for
7 days. The animals were anesthetized, blood was collected by car-
diac puncture at day 7, processed for plasma, aliquoted, and flash
frozen in liquid nitrogen. The animals were perfused with saline
and the gastrocnemius muscle was dissected and removed, flash
frozen in liquid nitrogen, and crushed to powder. A miRVana RNA
Isolation Kit was used to isolate total RNA, including small RNA,
from muscle and plasma samples. Illumina TruSeq Small RNA
library preparation was carried out using all of the RNA isolated
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from plasma and 1µg of tissue RNA. The samples were given indi-
vidual barcodes, pooled and loaded onto a version 2 or version 3
single read flow cell on the Illumina HiSeq 2000, clustered, and
sequenced for 50 cycles plus the indexing read. At the end of these
procedures, we had nine samples in each category.
Sequencing data from the Illumina HiSeq 2000 was processed
and de-multiplexed using the CASAVA pipeline to generate raw
fastq reads. Quality control checks on raw sequence data were
carried out using the FastQC tool. Quality filtering and other
pre-alignment processing steps, adapter clipping and read collaps-
ing, were carried out using the FASTX toolkit. Post-clipped reads
were then run through three different analysis packages: miRD-
eep2 (Friedländer et al., 2012), miRNAKey (v1.2; Ronen et al.,
2010), and miRExpress (V2.1.3; Wang et al., 2009). All the runs
were carried out using the optimal parameters suggested by the
developers and allowing the detection of up to a SNV.
DESCRIPTION OF ANALYSIS TOOLS USED FOR ALIGNMENT AND READ
COUNT GENERATION
miRDeep2
miRDeep2 is based on the miRNA biogenesis model, the ability
to predict a miRNA’s existence by detection of the mature miRNA
or any one of its precursor or stem loop sequences (Friedländer
et al., 2008). It consists of three modules: the miRDeep2 module
identifies known and novel miRNAs in high throughput sequenc-
ing data. The miRDeep2 core algorithm calls the RNA fold tool to
predict the RNA secondary structures and evaluates the structure
and signature of each potential miRNA precursor. If the struc-
ture resembles a miRNA hairpin and the reads fall in the hairpin
as would be expected from Dicer processing, then the poten-
tial precursor is assigned a score that reflects the likelihood of
it being a genuine miRNA. The Mapper module processes raw
sequences and maps the processed reads to the reference genome.
The Quantifier module sums up read counts for known miRNAs in
a sequencing data set. The output of this analysis is a scored list of
known and novel miRNAs with their expression levels (Friedlän-
der et al., 2012). For the comparative analysis we examined only
known miRNAs.
miRDeep2 predicts novel miRNAs based on the alignment of
the putative miRNA to the genome. In the results folder,miRDeep2
displays these reads and where they map to the reference genome.
The more sequences associated with any part of the pre-miRNA
sequence, the higher the score. The list of novel miRNAs created
by miRDeep2 is generated using an algorithm that scores the new
sequence based on the predictability of the up and downstream
stretches of genomic DNA (pri-miRNA sequence) to form a pre-
cursor miRNA with appropriate hairpin structure (pre-miRNA).
It also uses known miRNA sequences from orthologs to increase
or decrease the miRNA score. The results are reported as lists of
each known miRNA detected, as well as a miRDeep2 score for both
the known and predicted miRNAs (Friedländer et al., 2008).
One of the most interesting features of miRDeep2 is this
output of potential novel, unreported miRNAs (discovery). We
chose three unique sequences predicted by miRDeep2 to be
miRNAs for further evaluation with Taq qRT-PCR. The three
sequences were detected in at least 10 different gastrocnemius
muscle samples. The first sequence (Sequence 1) we examined
was “UCAGGUCCCUGUUCGGGCGCCA,” the miRDeep2 score
for this putative miRNA was very low, 0.9 on a scale from (−)10
to 10, however the number of reads detected with this sequence
was fairly high. The read counts varied from 62 to 835 across
the 10 samples. The sequence is most similar to mmu-miR-5097,
however, there are five bases that are different. We used custom Taq
probes specifically made for these putative miRNA sequences. Taq-
Man has high specificity; it uses two different probes to detect the
particular miRNA sequence: (1) a miRNA-specific sequence for
amplification and (2) a sequence-specific probe for detection of
the amplified product. Our qRT-PCR results, using a custom Taq
probe for the putative miRNA above, showed an average Cp value
of 19.7 across the Gastrocnemius muscle samples, there was no call
for the negative control (water) using these probes (Table 1). The
second sequence (Sequence 2) was: UCACCCUGGACUGACU-
CUCAGG, with a higher miRDeep2 score of 5.4 and a range of
read counts from 15 to 529. The sequence is similar to mmu-
miR-712-3p, six bases are different. The average Cp value in the
muscle samples for this custom probe was 36.9 (Table 1). Our
negative control did not amplify or give a Cp value. The third
novel sequence (Sequence 3) was: AGCCCCUCUGAGACUCU-
GAAAGA. This sequence did not have a large number of read
counts in any samples, range 2–85 across the 10 Gastrocnemius
samples. The miRDeep2 score ranged for this sequence across the
samples from 0.5 to 5.5. The score appeared to be heavily influ-
enced by the number of reads detected in the sample (a higher
miRDeep2 score with higher read counts). This sequence received
both the best and worst score of the three sequences we chose to
examine. The custom Taq probe showed no amplification for this
putative miRNA in the qRT-PCR reactions. This could be due to
several reasons, but the two easiest are either the probe was ineffi-
cient at detecting low expressing miRNAs, or the predicted miRNA
is not real. We would have to use additional methods to evaluate
Table 1 | qRT-PCR results for three potential novel miRNA sequences
predicted by miRDeep2.
Sequence Raw mapped
read counts
miRDeep2,
score
TaqMan
Cp value
Sequence 1
ucaggucccuguucgggcgcca
Sample 1: 759 0.9 19.57
Sample 2: 62 0.9 18.86
Sample 3: 271 0.9 19.36
Sequence 2
ucacccuggacugacucucagg
Sample 1: 373 5.4 36.22
Sample 2: 44 5.4 36.18
Sample 3: 15 5.4 37.27
Sequence 3
agccccucugagacucugaaaga
Sample 1: 49 5.5 –
Sample 2: 2 0.5 –
Sample 3: 6 2.5 –
Each putative miRNA sequence appeared in at least 10 different samples and each
sequence had a different miRDeep2 predicted score.The raw read counts, before
normalization, from three representative Gastrocnemius muscle samples are dis-
played. The Cp value for each sequence in each sample are reported. The same
total RNA concentration was used for each sample. The probes for Sequence 3
failed to amplify in any of the samples.
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the existence of Sequence 3. In summary, two of the three novel
sequences we chose to examine could be detected by TaqMan qRT-
PCR. Each of the three sequences was detected by NGS in at least
10 different gastrocnemius muscle samples.
miRNAKey
miRNAKey takes FASTQ sequencing files and aligns reads using
BWA (Li and Durbin, 2009) to the relevant database, in our case
miRBase 18. The software then can use an optional algorithm
(SEQ-EM) to optimize the distribution of multiple aligned reads
among the detected miRNAs, by not discarding them. It out puts
both expression (alignment to reference mature miRNAs) reads
counts and their normalized index based on the read count of each
input sample read file. The index consists of the read count nor-
malized to the number of (millions of) mapped reads in the input
sample; RPM= (the number of reads for that sequence÷ the total
number of reads)× 1,000,000 (Ronen et al., 2010).
miRExpress
miRExpress consists of three modules. The first module pre-
processes the sequences, e.g., adaptor removal, counting all of
the sequences that are identical and collapsing them into a single
sequence for alignment while retaining the information about the
number of reads. The second module carries out the alignments
by employing the Smith–Waterman algorithm. The third mod-
ule reports miRNA expression by calculating the sum of read
counts for each miRNA according to the alignment criteria cho-
sen by the investigator. For example, the read length vs. mature
miRNA length and percent identity of the alignment (Wang et al.,
2009). The sequenced reads can be aligned to the mature miRNA
sequence or to one of the precursor miRNA forms (pri or pre-
miRNAs). Once miRExpress has performed these alignments, it
takes the still unaligned reads and tries to align them to the known
miRNAs present in miRBase from other species, orthologs, in an
attempt to identify novel miRNAs (Wang et al., 2009).
An interesting and easy to use feature of the miRExpress pack-
age identifies where some of the unmapped reads go. In the results
file, the miRNA reads are displayed as they align to the precur-
sor sequence. This data reveals a category called “others” that is
not counted or presented in the standard miRNA output. These
are sequences that are slightly different from the mature miRNA
sequence in miRBase. For instance, the 3′ end of miRNAs are often
modified or shortened (Aravin and Tuschl, 2005; Landgraf et al.,
2007; Westholm et al., 2011; Juvvuna et al., 2012). The sequences
that match the reference miRNA but are a few nucleotides shorter
or longer or mismatched by more than our one allowable SNV,
FIGURE 1 | Screen shot of miRExpress output. Example of mature miRNA and isomiR alignment to a precursor miRNA.
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are aligned and exhibited in this result folder. These slightly vari-
able reads are called isomiRs. Figure 1 is a screen shot depicting
the alignment of mmu-mir-1249-5p and 3p and mmu-mir-671-
5p and 3p. The reads aligned under the mature sequence are the
reads that were detected in the sample and the read counts. Under
the line marked “Others” it displays sequences that were too short
or too variable to be counted in the output. In the example in
Figure 1, there are more miRNAs tallied in the “Others” category
for mmu-miR-671-5p than align to the mature miRNA sequence.
Therefore, the output to the results file is 6, rather than 51. Approx-
imately 1–12% of the reads end up in the “others” category for
Gastrocnemius muscle and are not counted as mapped reads in
the output. It would be interesting to assess what the biological
significance of these 3′ modifications are and whether or not they
are tissue or disease specific.
DETECTION OF miRNAS USING EACH APPLICATION
We examined the number of miRNAs that were detected by each
software tool. Figure 2 displays the number of miRNAs detected
in the mouse Gastrocnemius muscle and in the plasma samples
altogether by miRExpress, miRNAKey, and miRDeep2. miRDeep2
software detected and aligned more miRNAs than miRExpress or
miRNAKey; miRExpress and miRNAKey performed more simi-
larly. In this analysis we counted every miRNA, even those that
had only one detected read. We also adjusted the output from
each tool so that there were not duplicate counts for any mature
miRNAs.
We were also interested in the common overlapping miRNAs
and the distinct miRNAs expressed in each sample type we tested,
FIGURE 2 | Unique and overlapping miRNAs detected by each of the
three programs for two sample types. (A) Results of miRKey, miRDeep2,
miRExpress detection of miRNAs in the Gastrocnemius muscle samples.
Venn diagram displays the overlapping and unique number of miRNAs
detected by each program. (B) Results of miRKey, miRDeep2, miRExpress
detection of miRNAs in the plasma samples. Venn diagram displays the
overlapping and unique number of miRNAs detected by each program.
Gastrocnemius muscle and plasma. Those results are displayed in
Figure 3. There are∼100 miRNAs expressed in the muscle that are
not detected in the blood and∼50 distinct miRNAs are identified
in the plasma samples.
FINAL PERCENTAGE OF ALIGNED MATURE miRNA READS
The number of initial and mapped reads for each sample can vary
greatly for small RNA sequencing libraries. Variability is due to
several factors: (1) RNA isolation methods (the more small RNA
present the less adaptor dimers created during library prepara-
tion), (2) different tissue sources for the RNA isolation. Blood
samples perform very differently in library sample preparation
than tissue samples – this is most likely due to the lesser content of
small RNA present in that sample type. (3) Different amounts of
adaptor dimer contamination in the library preparation that are
not cut away during gel purification and are quantified and loaded
onto the sequencer. (4) Difficulty in accurately measuring small
FIGURE 3 | Display of the different numbers of detectable mature
miRNAs in each tissue type. (A) miRNAs detected in Gastrocnemius
Muscle and Plasma by miRExpress. (B) miRNAs detected in
Gastrocnemius Muscle and Plasma by miRKey. (C) miRNAs detected in
Gastrocnemius Muscle and Plasma by miRDeep2.
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FIGURE 4 |The distribution of the total reads to different categories of known RNA sequences after removing adaptor-only and poor quality reads.
pM values for each sample, 5000 pM of each sample are added to
the final sample pool to be loaded on a flow cell lane, accurate mea-
surement and loading of the final pools (9 pM) onto each lane of
the sequencer. (5) Clustering efficiency is highly impacted by the
size of the library. Because adaptor-only library contaminants are
slightly smaller than those containing miRNAs, they will cluster
more efficiently than the portion of the library containing real
RNA species.
We loaded ∼20 blood and ∼20 gastrocnemius samples onto
the sequencer, ∼20 samples per lane. From our library sam-
ple preparation of the Gastrocnemius muscle, we had an aver-
age of 6,565,492 initial reads per sample (median 4,557,315;
range 1,604,969–24,170,583). This wide range in the initial
sequences is due to the variability listed above. There was an
average of 5,634,555 post-clipped reads per sample (post-clipped
median 4,007,170; range 1,306,238–18,587,936). Post-clipped
reads= adaptor was trimmed, adaptor-only reads and reads that
were too short were removed. The number of mapped reads that
align to mature miRNA sequences from the post-clipped reads
depends in part on the analysis software used: miRNAKey, miRD-
eep2, or miRExpress, and the tissue type (Figures 2 and 3). And in
large part to the other categories of RNA sequenced in our samples
(Figure 4).
Plasma sample preparation was performed identically to the
Gastrocnemius muscle RNA, however, we had less initial start-
ing material and took all of the RNA isolated from the plasma
samples forward into the library sample preparation. The sam-
ples had an average of 5,948,616 initial reads (median 5,443,029;
range 690,892–16,535,938). 4,852,021 post-clipped reads (median
4,767,011; range 345,433–14,894,207). The percentage of the
sequences going to other categories of RNA was higher for the
blood (Figure 4).
From the post-clipped reads we then align all of the sequences
to miRBase. On average we get 68% mapped reads for the
Gastrocnemius muscle and 21% mapped reads from the plasma
samples (Figure 4). We examined what type of reads made up
the rest of the post-clipped sample library. We found that Rfam
(RNA family database) accounted for another 7% of the reads for
the Gastrocnemius muscle and ∼25% for the plasma. RepBase
(repeat sequences) made up 3% of the muscle and 0.21% of the
plasma sample library. The unclassified reads (Figure 4) made
up the second largest group of reads in the library and includes
several potential sequence types. A portion of them may come
from mature miRNAs with 3′ modifications or RNA editing of
the mature miRNA sequence so that it is not counted in the other
databases (∼1–12% of the total reads). Many of the reads are par-
tial mRNA sequences. And a portion of them map to the genome,
but cannot be currently classified as part of the other categories.
THE EFFECT OF DEPTH OF COVERAGE ON miRNA DETECTION
While sequencing costs have gone down, the cost of sequencing is
still not trivial. The depth of sequencing coverage is clearly linked
to a better estimation of the expressed miRNAs and downstream
differential expression analysis. High sequencing depth should
enrich the number of detected miRNAs and lower the false posi-
tive rate for significant differentially expressed miRNAs. However,
what is a good depth of coverage for small RNA sequencing? It can
become very costly to sequence small RNA samples over and over
to get the level of coverage desired. As shown in Figure 4, depend-
ing on your library preparation and the sample type, only 21–68%
of our reads mapped to mature miRNAs in miRBase. Similar per-
centages of mapped reads have been observed by other researchers
(Eipper-Mains et al., 2012). We wanted to try and understand
how depth of coverage would change our detection of miRNAs.
For each sample type, muscle, and plasma, there is a significant
amount of variability in the number of initial reads and reads that
map to mature miRNAs. Therefore, we examined the effects of
increasing mapped read counts on the ability to detect miRNAs in
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FIGURE 5 | New miRNA detection rate. (A) As a million reads at a time
are added to the sequencing depth of the Gastrocnemius Muscle, the
number of newly detectable miRNAs is reduced. Displayed are the
number of newly detected miRNAs with at least 1, 3, 5, 10, or 50 reads.
(B) As a million reads at a time are added to the sequencing depth of the
Plasma, the number of newly detectable miRNAs is reduced. Displayed
are the number of newly detected miRNAs with at least 1, 3, 5, 10, or 50
reads.
both muscle and blood. We used one sample from each tissue type
with a large number of initial and mapped reads as a representative
example.
We began with 500,000 randomly chosen post-clipped reads
and mapped them to miRBase using miRDeep2. We display the
number of detected miRNAs and their corresponding coverage: 1
mapped read only, at least 3 mapped reads, at least 5 mapped reads,
10 mapped reads, and 50 mapped reads. We increased the num-
ber of post-clipped reads going into the alignment incrementally
and calculated the number of new miRNAs that were detected
with each addition of reads (Figure 5). Not surprisingly, we found
that the more we increased the input of reads, the more miRNAs
we slowly included. The number of additional miRNAs detected
vs. the increased number of reads required has to be weighed for
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FIGURE 6 |The correlation of a subset of reads, beginning with 100,000
with the full number of mapped reads, 3.5 million.
each experiment. At the start of any experiment, we recommend
sequencing representative control samples for each tissue type to
a significant depth to examine the number of miRNAs that can
be detected and determine what number of detectable miRNAs is
suitable for your experiments.
EXAMINATION OF HOWWELL LOW DEPTH OF COVERAGE CAN
REPRESENT THE SAMPLE DISTRIBUTION
In addition to examining how the incremental increase in cover-
age altered the detection of new miRNAs in the sample, we wanted
to examine how well low numbers of mapped reads represented
the sample when compared with a very large number of mapped
reads. In other words, how well do a small subset of the reads
represent the distribution of miRNAs in the sample. This analysis
uses mapped reads whereas the previous analysis used post-clipped
reads. Using a plasma sample, we began with 100,000 randomly
chosen mapped reads, and incrementally increased the number of
reads we included by 100,000 up to 3.5 million. We then calculated
how well the subset of the lower numbers of read inputs, such as
100,000, correlated with the final total of 3.5 million mapped reads
(Figure 6). If the correlation is high with a low number of reads, it
suggests that low coverage may be sufficient to represent the sam-
ple. Selecting reads randomly (instead of miRNAs) preserves the
original distribution of reads from the sequencer. We report the
Spearman correlations using the three different tools: miRDeep2,
miRNAKey, and miRExpress. The correlation becomes fairly stable
at ∼1.5 million random reads, correlation coefficient of 0.97 for
miRNAKey. Our main observation was that increasing the reads
from 1 to 3 million reads only increased the Spearman correlation
by 0.05.
ANALYSIS OF THE NERVE CRUSH DATA
Our final analysis consists of data from the mice that received
a sciatic nerve crush compared with mice that received a sham-
surgery. The intent of this experiment was to identify miRNAs
specific to nerve crush/injury. We used only the reads that mapped
to known miRNAs for the analysis. We used each of the three
software packages: miRNAKey, miRDeep2, and miRExpress, and
analyzed the data using both DESeq and EdgeR (Tables 2–5).
In the Gastrocnemius muscle data, there was a lot of over-
lap (yellow and blue highlighted miRNAs) between the three tools
using EdgeR for analysis. With DESeq,we only got one significantly
different miRNA. The analysis of the plasma found significantly
different miRNAs using miRNAKey only. The plasma samples may
have been more variable since they had overall fewer mapped reads
per sample. It is also possible that a nerve crush injury, 7 days after
the insult is less detectable in blood. It would be interesting to
examine an earlier time point after nerve injury to see if more
miRNAs were detectable in blood. Perhaps changes in miRNA
expression, in response to nerve crush, remain local in the tissue
and do not become elevated in the blood. We would like to explore
this possibility further because researchers have begun looking for
miRNA biomarkers to indicate nerve-related injury and disease.
Because we were interested in the altered expression of miR-
NAs in response to nerve injury, and what the underlying relevance
might be to injury and repair processes, we examined the predicted
gene targets. We used miRNA Targets and Expression to examine
the predicted targets for the five differentially expressed miRNAs
that appeared across all 3 analysis tools using EdgeR (mmu-mir-
31-5p, mmu-mir1249-3p, mmu-mir-423-5p, mmu-mir-3102-3p,
mmu-mir-1247-5p; Enright et al., 2003; John et al., 2005; Betel
et al., 2008, 2010).
VALIDATION
We next wanted to validate the sequencing results using TaqMan
qRT-PCR. However, the use of qPCR to validate sequencing results
in these, and other, experiments has not proven to be straight for-
ward. There are several reasons for this: (1) sensitivity, we have
found that qPCR is not as sensitive as sequencing. qPCR has a
large dynamic range, measuring a few to millions of molecules.
But because the scale is logarithmic. The measurement between
a few molecules and millions fits on a scale between 5–30 cycles.
We display in Table 6 below, that although there is no detectable
difference in Cp values for qPCR, there are differences that can be
identified by sequencing, (2) cross-reactivity, the probes may cre-
ate some variability when comparing to sequencing due to closely
related isomiRs or miRNAs with single nucleotide changes that
qPCR cannot differentiate, (3) qPCR and sequencing are very
different platforms with different biases (loading, reference gene,
ligation, probe design, primer melting temperatures), it is difficult
to compare the results directly, (4) miRNAs are very small and the
sequence used for the RT reaction is limited by the sequence of
the miRNA. Therefore, the probe may not have optimal melting
temperatures or ideal linear amplification qualities. Nevertheless,
we report the average delta Cp values in the table below, using
a t test the delta Cp values are not significantly different. While
the qPCR results are not significantly different between groups,
we also display the read counts detected from sequencing the two
groups. Using a t test, the read counts are significant at p< 0.03.
In order to further illustrate some of the problems associated
with qPCR validation, we used three C. elegans synthetic miRNAs:
cel-39, cel-54, cel-238. We put 1.5µl of a 25 fmol stock of each
one in a mix and put them in 120µl of water. We carried 1.67µl
forward into three separate and specific RT reactions. We then
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Table 2 | Differentially expressed genes in the Gastrocnemius muscle detected using EdgeR for sham-surgery vs. nerve crush.
mirDeep2 miRExpress miRNAKey
mirName FC (log2) p-Value mirName FC (log2) p-Value mirName FC (log2) p-Value
mmu-mir-3969 4.471 0.000 mmu-miR-31-5p 2.187 0.010 mmu-miR-5115 −2.552 0.001
mmu-miR-31-5p 2.406 0.000 mmu-miR-483-5p −2.496 0.010 mmu-miR-31-5p 2.430 0.001
mmu-mir-5115 −2.259 0.001 mmu-miR-1249-3p −2.098 0.011 mmu-miR-5105 −2.862 0.008
mmu-mir-3962 2.696 0.003 mmu-miR-3102-3p −2.027 0.014 mmu-miR-1249-3p −2.059 0.016
mmu-miR-1249-3p −2.037 0.006 mmu-miR-423-5p −2.014 0.014 mmu-miR-1247-5p −2.098 0.026
mmu-miR-5105 −2.084 0.010 mmu-mir-5109 −1.954 0.016 mmu-miR-3102-3p −1.968 0.028
mmu-miR-423-5p −1.938 0.011 mmu-miR-1298-5p −3.896 0.028 mmu-miR-423-5p −1.917 0.000
mmu-miR-3102-3p −1.924 0.012 mmu-miR-1247-5p −1.811 0.043 mmu-miR-1298-5p −3.888 0.032
mmu-miR-1247-5p −1.910 0.014 mmu-miR-744-5p −1.841 0.032
mmu-miR-744-5p −1.705 0.042
Values in yellow highlight indicate differentially expressed miRNAs that were identified by all three alignment tools. Blue highlight are differentially expressed miRNAs
identified in two out of three tools. Results were filtered at corrected p-value<0.05. The results were truncated at the top 10 differentially expressed miRNAs for
miRDeep2.
Table 3 | Differentially expressed miRNAs in the Gastrocnemius muscle detected by DESeq for Sham-Surgery vs. nerve crush.
miRDeep2 miRExpress miRNAKey
miRNA Name FC (log2) p-Value miRNA Name FC (log2) p-Value miRNA Name FC (log2) p-Value
mmu-miR-3969 −4.2262 0.0098
Results were filtered at corrected p-value<0.05.
Table 4 | Differentially expressed genes in plasma detected using EdgeR for Sham-Surgery vs. nerve crush.
mirDeep2 miRExpress miRNAKey
mirName FC (log2) T, p-Value mirName FC (log2) p-Value mirName FC (log2) p-Value
mmu-miR-1a-3p 2.762 0.002
mmu-miR-411-5p 2.516 0.006
mmu-miR-378-3p 2.454 0.006
mmu-miR-133a-3p 2.330 0.011
mmu-miR-196a-5p 2.648 0.011
mmu-miR-9-5p 2.129 0.028
mmu-miR-381-3p 2.190 0.028
mmu-miR-153-3p 2.426 0.028
mmu-miR-708-5p 2.624 0.030
mmu-miR-411-3p 2.641 0.038
Results were filtered at corrected p-value<0.05.
Table 5 | Differentially expressed miRNAs in plasma detected by DESeq for Sham-Surgery vs. nerve crush.
miRDeep2 miRExpress miRNAKey
miRNA Name FC (log2) p-Value miRNA Name FC (log2) p-Value miRNA Name FC (log2) p-Value
mmu-miR-133a-3p −2.49 0.028
mmu-miR-1a-3p −3.01 0.028
mmu-miR-378-3p −2.65 0.028
Results were filtered at corrected p-value<0.05.
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Table 6 | qPCR results.
GASTROCNEMIUS MUSCLE – AVERAGE DELTA Cp VALUES
mmu-31 mmu-1247-5p mmu-3102-3p mmu-3969
Crush 8.6 9.4 7.5 7.8
Sham 7.8 8.8 8.2 9.4
MMU-31 DELTA Cp VALUES FOR 5 MUSCLE SAMPLES
Crush 8.50 11.40 7.74 8.91 8.65
Sham 7.32 9.47 10.17 6.36 5.89
SEQUENCING READ COUNTS FOR MMU-31
Crush 13 4 125 47 55 8 20 31 15
Sham 47 525 55 15 11 274 257 229
PLASMA –AVERAGE DELTA Cp
mmu-133-3p mmu-1a-3p
Crush 0.74 1.68
Sham 2.99 0.03
The first table is the average Cp values for the crush and sham groups for top dif-
ferentially expressed miRNAs. The first three are shared across all groups using
EdgeR mmu-31, 1247, 3102. mmu-3969 was the only miRNA detected by DESeq
for the muscle samples. Below that we show the delta Cp values for five samples
from each group. Then we display the sequencing read counts for each muscle
for mmu-31. Forth, we show the average delta Cp for the plasma miRNAs. The
reference was U6.
used a specific Taq probe for each. We had the following Cp val-
ues: cel-39 (Cp 17.9), cel-238 (20.3), cel-54 (18.3). We diluted the
RT reaction in half and got the following Cp values: cel-39 (17.3),
cel-238 (21.8), cel-54 (18.7). Taq is not sensitive enough to pick
up the difference in half the molecules at this range.
DISCUSSION
We began our sequencing studies with the intent to identify specific
miRNAs related to nerve injury. Our goal was to examine miRNAs
that were expressed at significantly different levels between mice
with a traumatic injury, inflammation, and damage associated
with an injury where the skin and muscle (quadriceps) were cut
and then repaired (sham-surgery) compared with miRNAs dif-
ferentially expressed in mice that received the same insult plus a
crushed nerve (sciatic). The experiment was to detect differen-
tially expressed miRNAs resulting specifically from nerve injury
in an affected muscle downstream of the crushed nerve. The Gas-
trocnemius muscle is innervated by the sciatic nerve, but was not
directly damaged by our surgical procedures. We isolated RNA
from the Gastrocnemius muscle and peripheral blood plasma and
used NGS as our assay.
We tested the ability of miRDeep2 to predict novel miRNAs by
attempting to validate the miRNA sequence with a second type of
detection, custom TaqMan qRT-PCR probes. We found that the
appearance of the novel miRNA sequence in multiple samples,
with a high number of detected reads, helped lend confidence to
the existence of the miRNA. We were unable to detect one of the
miRNAs in any of the samples, either the probes were inefficient at
detecting that sequence at that level of expression, or the sequence
is not a true miRNA. Additional tests are required.
There was a significant amount of upfront information that
needed to be collected before we could carry out our experiments.
We needed to know how each sample type (tissue vs. plasma)
would perform on the sequencer. For instance, what percent of
the initial sequenced reads would map to known mature miRNAs?
How does the sequence coverage affect miRNA detection, and how
many mapped reads are required to best represent the sample?
We also wanted to explore some of the most cited software tools
for aligning and reporting mature miRNA counts. We also exam-
ined some of the additional features provided by each software
package. All of these pieces of information, weighed against the
resources and costs required to sequence the samples to a suitable
depth, determined how the sequencer was loaded; the number of
barcoded samples per lane and how the data was analyzed.
One of the most surprising outcomes from our sequencing
data was the overall low percentage of mapped reads, on average
∼21–68% of all of the reads mapped to known mature miRNAs.
There were several other categories of RNA that took up a large
proportion of our reads. This made it more difficult to achieve
a high depth of coverage, especially for plasma samples. A large
portion of the reads went to an unassigned category. These could
be mRNA, or they aligned to the genome but were unknown, or
contamination.
We went on to consider the number of new miRNAs detected
with the addition of a million reads. Many researchers use a min-
imum of 10 read counts for a particular miRNA as a cutoff for
inclusion in the final analysis (Dhahbi et al., 2011; Hu et al., 2011).
Therefore, if we look only at the addition of new miRNAs that
have at least 10 reads (Figure 5A), at a total of 5 million reads,
you include 24 new miRNAs. If you add a million post-clipped
reads making the total now 6 million reads, you include an addi-
tional ∼17 new miRNAs with at least 10 reads are included. At 7
million, 14 new miRNAs, at 8 million (14 miRNAs), 9 million (8
miRNAs), and at 10 million reads (6 miRNAs). That is a total of
83 new miRNAs detected between 5 and 10 million reads for the
Gastrocnemius muscle. For the plasma sample, we add 58 newly
detected miRNAs between 5 and 9 million reads. We conclude,
therefore, that individual investigators need to examine the prop-
erties of their samples to decide what depth of coverage would be
best for their experiments.
When we looked at the Spearman Correlation and how well
1.5 million mapped reads correlated with more than double that
number (3.5 million mapped reads), it was 0.97. If this were a
typical plasma sample with ∼20% of the initial reads mapping
to known miRNAs, 3.5 million mapped read counts would come
from ∼17.5 million initial read counts. To get just the 1.5 million
mapped reads, the input reads would have to be 7.5 million reads
from the sequencer. The numbers of reads required to get just a
million mapped reads quickly becomes very high and difficult to
support.
Taking all of these things into consideration along with the cost
and resources necessary to continue sequencing each of these sam-
ples, the samples included in the Gastrocnemius muscle analysis
all had at least 1,000,000 mapped reads, except two samples that
each had>650,000 mapped reads. We did have to settle for a much
smaller number of mapped reads in the plasma samples. The aver-
age number of reads that went into the analysis at the end was
∼500,000 reads for each sample.
Once we had our samples for the analysis, we examined the
outputs of both EdgeR and DESeq, common analysis tools for
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sequencing data. In general, DESeq identified many fewer signifi-
cant differentially expressed miRNAs. Possibly because of the lower
read count increasing the variability in the plasma samples, or pos-
sibly due to biology, and only a very small affect of nerve injury
in the leg on miRNA changes in the blood, but there were many
fewer differentially expressed miRNAs detected in plasma.
We attempted to validate our sequencing findings using qRT-
PCR. In many ways qPCR is inferior to sequencing when
measuring small, but significant, changes in RNASeq or in
miRNASeq. qPCR has been an excellent method for validating
data such as microarrays, but perhaps we need to identify a new
way to validate sequencing results. We illustrated several reasons
for this above. Among the reasons we mentioned, the logarithmic
nature of qPCR results make it difficult to detect modest changes
in molecule numbers. In our example, cutting the reaction in half
made no detectable difference to the qPCR Cp values in the ranges
we detect miRNAs.
There is a lot of value in using NGS technologies to assess
miRNA profiles. Investigators can detect, isomiRs, subtle changes
in miRNA expression and potential novel undiscovered miR-
NAs. There are many tools that can be used to analyze the
data. We investigated some of them using a dataset for nerve
injury.
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